BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38274096)

  • 1. Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy.
    Liu Y; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
    Front Mol Biosci; 2023; 10():1277508. PubMed ID: 38274096
    [No Abstract]   [Full Text] [Related]  

  • 2. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
    Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
    Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
    Yang X; Miao Y; Wang J; Mi D
    Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of
    Li L; Li F; Xu Z; Li L; Hu H; Li Y; Yu S; Wang M; Gao L
    Front Pharmacol; 2023; 14():1213891. PubMed ID: 37680718
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets.
    Liu Y; Li X; Yang J; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
    Heliyon; 2024 Apr; 10(8):e29655. PubMed ID: 38655365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
    Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
    Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated pan-cancer analysis of identifying biomarkers about the EGR family genes in human carcinomas.
    Hua Y; Wang H; Ye Z; Zheng D; Zhang X
    Comput Biol Med; 2022 Sep; 148():105889. PubMed ID: 35933961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Feng L; Li G; Li D; Duan G; Liu J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
    Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
    Front Immunol; 2022; 13():900273. PubMed ID: 36159856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
    Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
    Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
    Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
    Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity.
    Chen Z; Zhao Y; Tian Y; Cao R; Shang D
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
    Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
    Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 19. High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma.
    Zhang H; Yan X; Gu H; Xue Q; Liu X
    J Thorac Dis; 2022 Dec; 14(12):4785-4802. PubMed ID: 36647484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
    Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
    Front Immunol; 2022; 13():943389. PubMed ID: 36003381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.